Clinical trial Recruiting at 24 sites Observational Ages 1 Month to 100

Evaluation of individuals with undiagnosed genetic disorders

Official title: Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Run by National Institutes of Health Clinical Center (CC) · NCT02450851 · Data updated 2026-11-12

This study is trying to help people with undiagnosed genetic disorders by using expert evaluations and genetic testing to find answers about their conditions.

More Genetic Disease trials

Quick facts

Study typeObservational
Ages1 Month to 100 Years
SexAll
Enrollment20000 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations33 sites (Birmingham, Alabama and 32 other locations)
StatusRecruiting
StartedSeptember 16, 2015
Main results expectedSeptember 16, 2099
Study endsDecember 31, 2099
Registry record updatedNovember 3, 2026
Trial IDNCT02450851 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with unexplained symptoms and objective findings who have not received a diagnosis despite extensive evaluations by specialists.

Probably not a fit

Patients with a known diagnosis that explains their symptoms or those without relevant objective findings are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to provide answers for individuals suffering from undiagnosed genetic diseases by utilizing a collaborative network of experts. Participants undergo comprehensive evaluations, including genetic testing and phenotyping, to identify potential diagnoses and understand disease mechanisms. The study also seeks to generate new knowledge about rare diseases and assess innovative approaches to diagnosis and treatment. By sharing data and biomaterials among research centers, the initiative aims to enhance the understanding of these complex conditions.

Why it matters

Potential benefit: If successful, this study could lead to accurate diagnoses and improved management strategies for patients with previously undiagnosed genetic disorders.

How similar studies have gone: Previous initiatives like the NIH Undiagnosed Diseases Program have successfully identified rare disease diagnoses, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

Ideal participants for tier 2-4 evaluations include individuals with:

* One or more objective findings pertinent to the phenotype for which a case was submitted.
* No diagnosis despite evaluation by specialists who assessed the patient for the objective finding(s).
* Agreement for the storage and sharing of information and biomaterials, in an identified fashion amongst the UDN centers, and in a de-identified fashion to research sites beyond the network.

Participants unable to consent can be enrolled.

EXCLUSION CRITERIA:

Individuals who are unlikely to be assigned to tier 2-4 evaluations include those with:

* Reported symptoms with no relevant objective findings.
* A diagnosis explaining objective findings.
* A diagnosis suggested on record review.
* Unwillingness to share data.

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • University of California, Los Angeles
    Los Angeles, California, United States
    Recruiting
  • University of California, Irvine Medical Center
    Orange, California, United States
    Recruiting
  • Stanford University
    Stanford, California, United States
    Recruiting
  • Leland Stanford Junior University
    Stanford, California, United States
    Recruiting
  • Stanford Hospital and Clinics
    Stanford, California, United States
    Recruiting
Show 27 more locations
  • Childrens National Medical Center
    Washington D.C., District of Columbia, United States
    Recruiting
  • University of Miami Miller School of Medicine
    Miami, Florida, United States
    Recruiting
  • Indiana University
    Indianapolis, Indiana, United States
    Recruiting
  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Boston Children s Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • Washington University in St. Louis
    St Louis, Missouri, United States
    Recruiting
  • Duke University Health System
    Durham, North Carolina, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting
  • Baylor College of Medicine
    Houston, Texas, United States
    Recruiting
  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting
  • Seattle Children's Hospital
    Seattle, Washington, United States
    Recruiting
  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting
  • HudsonAlpha Institute for Biotechnology, Inc.
    Huntsville, Alabama, United States
    Completed
  • Lucile Salter Packard Children's Hospital at Stanford
    Stanford, California, United States
    Completed
  • Lurie Children s Hospital
    Chicago, Illinois, United States
    Not yet recruiting
  • Harvard T.H. Chan School of Public Health
    Boston, Massachusetts, United States
    Completed
  • Harvard U Faculty of Medicine
    Boston, Massachusetts, United States
    Not yet recruiting
  • New York Genome Center
    New York, New York, United States
    Active not recruiting
  • University of Oregon
    Eugene, Oregon, United States
    Not yet recruiting
  • Oregon Health Sciences University
    Portland, Oregon, United States
    Completed
  • Pacific Northwest National Laboratory
    Richland, Washington, United States
    Completed

Study contacts

  • Principal investigator: William A Gahl, M.D. — National Human Genome Research Institute (NHGRI)
  • Study coordinator: Paul Mazur
  • Email: udn@hms.harvard.edu
  • Phone: (844) 746-4836

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.